This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Kemper Corporation (KMPR) Stock a Solid Choice Right Now?
by Zacks Equity Research
Kemper Corporation (KMPR) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
MetLife (MET) Expands Coverage to Include Diabetic Patients
by Zacks Equity Research
The expansion of coverage by MetLife Hong Kong, a wholly owned subsidiary of MetLife (MET), intends to make medical facilities easily accessible for diabetic patients.
Prudential Financial's (PRU) Subordinated Notes Get Rated
by Zacks Equity Research
Ratings of Prudential Financial's (PRU) subordinated notes by credit rating agencies reflect its robust performance across all its segments.
Radian Group Raises Notes Offering to $450M, Gets Rated
by Zacks Equity Research
Radian Group (RDN) raises senior notes offering to fund tender offers as well buyback outstanding debts. The ratings by Moody's reflect the company's refined profitability standards.
MGIC Investment vs. Radian Group: Which Stock Fares Better?
by Zacks Equity Research
On comparative analysis, we try and find out which stock -- Radian Group (RDN) or MGIC Investment (MTG) -- is better positioned in terms of fundamentals.
Cigna's (CI) Unsecured Debts Receive Ratings From Moody's
by Zacks Equity Research
Unsecured debt ratings of Cigna assigned by Moody's reflect the company's robust business profile and wide national presence.
Add These 4 Insurance Outperformers to Boost Your Portfolio
by Zacks Equity Research
We zero in on four insurance industry outperformers -- American Financial (AFG), First American Financial (FAF), American Equity Investment (AEL) and Kemper (KMPR) -- that you may buy for better yields.
Primerica (PRI) and Units' Ratings Retained by A. M. Best
by Zacks Equity Research
The ratings of Primerica (PRI) and its affiliates by A.M. Best reflect the company's solid market presence and sturdy capital position.
Cigna (CI) Assigned Shelf Ratings by Moody's, Outlook Stable
by Zacks Equity Research
Shelf ratings of Cigna assigned by Moody's reflect the company' s robust business profile and wide national presence.
Forget MetLife (MET), Buy These 3 Insurance Stocks Instead
by Zacks Equity Research
MetLife's (MET) declining revenues from low premiums, fees and other revenues, macroeconomic factors, and low return on equity make it an unattractive stock now.
Can Kemper Corporation (KMPR) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
Kemper Corporation (KMPR) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.
Zacks Industry Outlook Highlights: Health Insurance Innovations, Kemper Corporation and CNO Financial Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Health Insurance Innovations, Kemper Corporation and CNO Financial Group
U.S. Insurance Stock Outlook - August 2017
by Kalyan Nandy
U.S. insurers don't appear to have attracted special attention of investors amid this gradually improving interest rate environment.
Looking for a Top Momentum Stock? 3 Reasons Why Kemper (KMPR) is a Great Choice
by Zacks Equity Research
Kemper Corporation (KMPR) stock is looking quite impressive now for momentum-oriented investors.
Insurance Stock Q2 Earnings Due on Jul 26: XL, TMK & More
by Zacks Equity Research
Insurers' Q2 results are likely to benefit from core business growth, higher premiums and an improving rate environment. Volatile underwriting due to catastrophe loss might weigh on the upside.
Donegal Group Estimates Catastrophe Loss, Sees Loss in Q2
by Zacks Equity Research
Massive weather-related loss ($20.1 million) and fire losses ($7.6 million) drive Donegal Group (DGICA) (DGICB) toward a disappointment in Q2.
Kemper (KMPR) Estimates $32M to $38M in Q2 Catastrophe Loss
by Zacks Equity Research
Kemper Corporation's (KMPR) high estimated pre-tax catastrophe loss for the second-quarter 2017 will likely upset its underwriting results.
New Strong Sell Stocks for July 13th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Kemper Announces Pricing of $200 Senior Notes, Moody's Rates
by Zacks Equity Research
Kemper Corporation (KMPR) has recently announced the offering of 4.350% $200 million senior notes. Moody's Investor Service -- an affiliate of Moody's Corporation (MCO) -- assigned Baa3 rating with stable outlook to the senior notes.
MGIC Investment (MTG): Time to Add the Stock to Portfolio?
by Zacks Equity Research
Shares of MGIC Investment Corporation (MTG) gained 6.32% since Jan 19 when the insurer the reported better than expected fourth-quarter 2016 earnings. It significantly outperformed the Multi line industry's growth of 2.55%.
Kemper (KMPR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Kemper Corporation (KMPR) reported fourth-quarter 2016 net operating income of 56 cents per share, which surpassed the Zacks Consensus Estimate of 42 cents by 33.3%.
Aflac's Senior Unsecured Notes Get Debt Rating from Moody's
by Zacks Equity Research
Aflac Incorporated (AFL) recently received rating action from Moody's Investors Service, a wing of Moody's Corporation (MCO).
Aon (AON) Acquires Admix, Bolsters Footprint in Brazil
by Zacks Equity Research
Aon Plc (AON) recently announced that it has completed its acquisition of Brazilian benefits brokerage and solutions provider, Admix.
Why You Should Hold onto MGIC Investment (MTG) Stock
by Zacks Equity Research
Shares of MGIC Investment Corporation (MTG) gained 40.11% in the last one year, significantly outperforming the Multi line industry's growth of 23.42%.
Why You Should Retain American International (AIG) Stock
by Zacks Equity Research
On Jan 17, 2017, we issued an updated research report on American International Group, Inc. (AIG).